BIOMAT Database Logo BIOMAT Database Logo

N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins. 2007

Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
Lipid Research Group, Heart Research Institute, Camperdown, New South Wales 2050, Australia.

Endothelial lipase (EL) is a member of the triglyceride lipase gene family with high phospholipase and low triacylglycerol lipase activities and a distinct preference for hydrolyzing phospholipids in HDL. EL has five potential N-glycosylation sites, four of which are glycosylated. The aim of this study was to determine how glycosylation affects the phospholipase activity of EL in physiologically relevant substrates. Site-directed mutants of EL were generated by replacing asparagine (N) 62, 118, 375, and 473 with alanine (A). These glycan-deficient mutants were used to investigate the kinetics of phospholipid hydrolysis in fully characterized preparations of spherical reconstituted high density lipoprotein (rHDL) containing apolipoprotein E2 (apoE2) [(E2)rHDL], apoE3 [(E3)rHDL], apoE4 [(E4)rHDL], or apoA-I [(A-I)rHDL] as the sole apolipoprotein. Wild-type EL hydrolyzed the phospholipids in (A-I)rHDL, (E2)rHDL, (E3)rHDL, and (E4)rHDL to similar extents. The phospholipase activities of EL N118A, EL N375A, and EL N473A were significantly diminished relative to that of wild-type EL, with the greatest reduction being apparent for (E3)rHDL. The phospholipase activity of EL N62A was increased up to 6-fold relative to that of wild-type EL, with the greatest enhancement of activity being observed for (E2)rHDL. These data show that individual N-linked glycans have unique and important effects on the phospholipase activity and substrate specificity of EL.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008049 Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. It is produced by glands on the tongue and by the pancreas and initiates the digestion of dietary fats. (From Dorland, 27th ed) EC 3.1.1.3. Triacylglycerol Lipase,Tributyrinase,Triglyceride Lipase,Acid Lipase,Acid Lipase A,Acid Lipase B,Acid Lipase I,Acid Lipase II,Exolipase,Monoester Lipase,Triacylglycerol Hydrolase,Triglyceridase,Triolean Hydrolase,Hydrolase, Triacylglycerol,Hydrolase, Triolean,Lipase A, Acid,Lipase B, Acid,Lipase I, Acid,Lipase II, Acid,Lipase, Acid,Lipase, Monoester,Lipase, Triglyceride
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E

Related Publications

Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins.
June 2006, Journal of lipid research,
Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
Apolipoproteins regulate the kinetics of endothelial lipase-mediated hydrolysis of phospholipids in reconstituted high-density lipoproteins.
September 2004, Biochemistry,
Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
Role of apolipoprotein E in hepatic lipase catalyzed hydrolysis of phospholipid in high-density lipoproteins.
March 1992, Biochemistry,
Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
The molecular behavior of apoA-I in human high density lipoproteins.
March 1975, The Journal of biological chemistry,
Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
On the structural similarity of ApoA-I and ApoA-II of human high density lipoproteins.
January 1978, Biochemical and biophysical research communications,
Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response.
February 2001, Journal of lipid research,
Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins.
August 2010, Circulation research,
Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
The influence of apolipoproteins on the hepatic lipase-mediated hydrolysis of high density lipoprotein phospholipid and triacylglycerol.
October 1998, The Journal of biological chemistry,
Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
Evidence that apolipoprotein A-I facilitates hepatic lipase-mediated phospholipid hydrolysis in reconstituted HDL containing apolipoprotein A-II.
May 2001, Biochemistry,
Danielle Skropeta, and Chatri Settasatian, and Monica R McMahon, and Kate Shearston, and Daniela Caiazza, and Kristine C McGrath, and Weijun Jin, and Daniel J Rader, and Philip J Barter, and Kerry-Anne Rye
Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro.
February 2004, Journal of lipid research,
Copied contents to your clipboard!